Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 029L20A | IM / LA |
Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION; Narrative: Patient was living independently for approximately one month following being a resident at a long term facility. Patient received two doses of the Moderna Covid-19 vaccine (12/29/2020 & 01/26/2021). On 09/28/2021 patient presented to an emergency department at a different facility where he tested positive for the COVID-19 infection. Patient had stopped taking all his home medications (including but limited to carbidopa/levodopa, quetiapine and ropinirole) without tapering or under the advisement of a physician due to his caretaker also being sick with the infection. Patient was transferred to the local facility for quarantine and supportive care. All medications were re-initiated. The COVID-19 pneumonia infection did not require any treatment. Patient had no where to discharge to until 10/14/2021 when he returned back to the long term care facility he had lived at previously. Other Relevant HX: Past medical history relevant for: T2DM, deep brain stimulation, GERD, parkinsonism, anxiety disorder, hyperlipidemia Other: COVID-19 Breakthrough Infection
Positive COVID-19 PCR test (09/29/2021)